Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objectives Because in obese youth, pulse wave velocity (PWV), an early CVD marker, is elevated, we tested if obese girls with PCOS have higher PWV and carotid intima-media thickness (cIMT) compared with obese and normal-weight control girls without PCOS and whether PWV and cIMT correlate with inflammatory and circulating endothelial function biomarkers. Study design Cross-sectional study of PWV and cIMT in 91 obese girls with PCOS (OB-PCOS), 30 obese controls (OB-non-PCOS), and 19 normal-weight controls (NW-non-PCOS). Body composition, blood pressure, fasting glucose, insulin, lipid concentrations and endothelial function biomarkers were measured. OB-NonPCOS and OB-PCOS girls underwent 2-hour oral glucose tolerance testing. Results PWV was higher in OB-PCOS (664±24 cm/s) and OB-NonPCOS (624±37 cm/s) compared with NW-NonPCOS (468±13 cm/s, p<0.001), with no differences in cIMT. Systolic BP (SBP), LDL and non-HDL cholesterol were higher, and HDL cholesterol and indices of insulin sensitivity were lower in OB-PCOS and OB-NonPCOS compared with NW-NonPCOS. Vascular cell adhesion molecule-1 (VCAM-1) and hsCRP were higher in OB-PCOS compared with NW-NonPCOS. PWV correlated with adiposity (rs=.46), insulin sensitivity index (HOMA-IR rs=.31), SBP (rs=.24; p ≤0.003 for all) and free testosterone (rs=.24; p=0.03). In multiple regression analysis with PWV as the dependent variable and age, race, BMI, PCOS and dysglycemia as independent variables, only BMI was an independent contributor to the model (r2=0.068, p=0.003). Conclusions In adolescent girls, obesity and not PCOS appears to be associated with heightened CVD risk. Increased PWV, VCAM-1 and hsCRP may be the earliest subclinical atherosclerosis biomarkers in obese girls with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedPrediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
Vlachopoulos, C., Aznaouridis, K., & Stefanadis, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.061 · Cited by 4,165
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Self-citationWild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970 · cited 2×
“Two large prospective studies each with greater than 20 years of follow-up found that there was no increased prevalence of nonfatal/fatal CVD events in women with PCOS.(8,9) On the other hand, a subanalysis of the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation study found that…”
BackgroundMortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · cited 2×
“Two large prospective studies each with greater than 20 years of follow-up found that there was no increased prevalence of nonfatal/fatal CVD events in women with PCOS.(8,9) On the other hand, a subanalysis of the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation study found that…”
BackgroundPolycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · cited 1×
“Despite the growing evidence of subclinical CVD in adult women with PCOS, the increased risk for CVD in them remains controversial.(29) Two large prospective studies each with greater than 20 years of follow-up found that there was no increased prevalence of nonfatal/fatal CVD events in women with PCOS.”
BackgroundScreening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
Palmert, M. R., Gordon, C. M., Kartashov, A. I., Legro, R. S., Emans, S. J., & Dunaif, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8305 · Cited by 354 · cited 1×
“Moreover, impaired glucose tolerance and type 2 diabetes mellitus are more prevalent in both adult women and adolescents with PCOS.(4,5) In women with PCOS, evidence of subclinical CVD was shown by increased pulse wave velocity (PWV) and carotid intima-media thickness (cIMT).”
BackgroundEarly metabolic abnormalities in adolescent girls with polycystic ovarian syndrome
Lewy, V. D., Danadian, K., Witchel, S. F., & Arslanian, S. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.109603 · Cited by 298
Self-citationOverweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
Meyer, C., McGrath, B. P., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0011 · Cited by 273 · cited 2×
“However, in addition to IR, long-standing hyperandrogenemia may play a role in vascular changes observed in adulthood.(6) Even though free testosterone correlated with PWV in our obese adolescents, lack of a significant contribution of the PCOS condition to the variance in PWV in the regression model suggests that PCO…”
BackgroundMcLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268 · cited 2×
“Moreover, impaired glucose tolerance and type 2 diabetes mellitus are more prevalent in both adult women and adolescents with PCOS.(4,5) In women with PCOS, evidence of subclinical CVD was shown by increased pulse wave velocity (PWV) and carotid intima-media thickness (cIMT).”
BackgroundMeyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175 · cited 2×
“In addition, numerous adult studies have shown adverse structural changes in cIMT in premenopausal women with PCOS compared with age and/or BMI-matched controls without PCOS.(27) Furthermore, coronary artery and aortic calcification are increased in women with PCOS compared with controls, with the presence of PCOS, ag…”
BackgroundResultLass, N., Kleber, M., Winkel, K., Wunsch, R., & Reinehr, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1609 · Cited by 160
Meyer, C., McGrath, B. P., & Teede, H. J. (2007) · Diabetes Care · doi:10.2337/dc06-0618 · Cited by 148 · cited 1×
“In adult women with PCOS, improvement in insulin sensitivity with troglitazone was associated with reduced cIMT progression rates, and worsening of insulin sensitivity with high dose OCP was associated with increased arterial stiffness.(31,32) Elevated TG/HDL, a marker of IR and/or the metabolic syndrome both in adult…”
BackgroundRossi, B., Sukalich, S., Droz, J., Griffin, A., Cook, S., Blumkin, A., Guzick, D. S., & Hoeger, K. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1198 · Cited by 120
Glueck, C. J., Morrison, J. A., Friedman, L. A., Goldenberg, N., Stroop, D. M., & Wang, P. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.003 · Cited by 65
Zachurzok-Buczynska, A., Szydlowski, L., Gawlik, A., Wilk, K., & Malecka-Tendera, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.043 · Cited by 20
Cited by
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Basu, B., Chowdhury, O., & Saha, S. (2018) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_78_17 · Cited by 61
“[3] However, in addition to its reproductive features, PCOS also has numerous metabolic consequences including increased risk of obesity,[4] insulin resistance,[5] type 2 diabetes mellitus,[6] and premature atherosclerosis.[7] Many women with PCOS meet the criteria for metabolic syndrome (MBS) as they report a higher…”
BackgroundAnti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.10.015 · Cited by 54
Fu, L., Xie, N., Qu, F., Zhou, J., & Wang, F. (2023) · Reproductive Sciences · doi:10.1007/s43032-022-00864-8 · Cited by 49
“Even at a young age, adolescents with PCOS manifest significant insulin resistance and impaired glucose tolerance [33] and have increased risk factors for cardiovascular disease compared with controls [26, 34].”
BackgroundMethodResultInfluentialJaved, Z., Papageorgiou, M., Madden, L. A., Rigby, A. S., Kilpatrick, E. S., Atkin, S. L., & Sathyapalan, T. (2020) · Endocrine Connections · doi:10.1530/ec-20-0173 · Cited by 24
Metadata
- Authors
- Hughan, K. S., Tfayli, H., Warren-Ulanch, J. G., Barinas-Mitchell, E., & Arslanian, S. A.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 168
- Pages
- 104-111.e1
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W1948724452
- Cited by
- 53
- References
- 16
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.